1. Home
  2. HUBS vs NTRA Comparison

HUBS vs NTRA Comparison

Compare HUBS & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HubSpot Inc.

HUBS

HubSpot Inc.

HOLD

Current Price

$377.40

Market Cap

23.8B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBS
NTRA
Founded
2005
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8B
27.0B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
HUBS
NTRA
Price
$377.40
$244.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
30
16
Target Price
$626.87
$227.69
AVG Volume (30 Days)
833.8K
1.7M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,987,698,000.00
$2,116,676,000.00
Revenue This Year
$20.84
$32.77
Revenue Next Year
$16.03
$16.51
P/E Ratio
N/A
N/A
Revenue Growth
19.21
38.17
52 Week Low
$344.41
$125.38
52 Week High
$881.13
$245.59

Technical Indicators

Market Signals
Indicator
HUBS
NTRA
Relative Strength Index (RSI) 41.61 80.03
Support Level $364.00 $233.67
Resistance Level $381.70 $240.18
Average True Range (ATR) 13.79 7.39
MACD 4.30 0.68
Stochastic Oscillator 67.68 97.49

Price Performance

Historical Comparison
HUBS
NTRA

About HUBS HubSpot Inc.

HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: